RxSight (RXST) Operating Leases (2020 - 2026)

RxSight (RXST) has reported Operating Leases for 7 consecutive years, with $8.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Operating Leases fell 16.0% year-over-year to $8.9 million; the trailing twelve-month figure through Jun 2026 stood at $8.9 million (down 16.0% YoY), and the FY2025 full-year result was $9.9 million, down 12.75% from the prior year.
• Operating Leases eased to $8.9 million in Q2 2026 per RXST's latest filing, from $9.3 million in the prior quarter.
• Across five years, Operating Leases topped out at $11.3 million in Q4 2024 and bottomed at $908000.0 in Q1 2024.
• Historically, Operating Leases has averaged $6.3 million across 5 years, with a median of $6.4 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Operating Leases slumped 61.16% in 2024, then jumped 1110.02% in 2025.
• Over 5 years, Operating Leases stood at $2.9 million in 2022, then plunged by 57.6% to $1.2 million in 2023, then soared by 834.93% to $11.3 million in 2024, then slipped by 12.75% to $9.9 million in 2025, then slipped by 9.74% to $8.9 million in 2026.
• According to Business Quant data, Operating Leases over the past three periods registered $8.9 million, $9.3 million, and $9.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.